2586 J ournal of Medicinal Chemistry, 1997, Vol. 40, No. 16
Bryant et al.
(13) (a) Arakawa, K.; Akami, T.; Okamoto, M.; Akioka, K.; Nakai, I.;
Oka, T.; Nagase, H. Immunosuppression by Delta Opioid Recep-
tor Antagonist. Transplant. Proc. 1993, 25, 738-740. (b) Chien,
S.; Oeltgren, P. R.; Diana, J . N.; Salley, R. K.; Su, T.-P. Extension
of Tissue Survival Time in Multiorgan Block Preparation with
a Delta Opioid DADLE ([D-Ala2,D-Leu2]-Enkephalin). J . Thorac.
Cadiovasc. Surg. 1994, 107, 964-967. (c) Caroleo, M. C.;
Arbitrio, M.; Melchiorri, D.; Nistico`, G. A Reappraisal of the Role
of the Various Opioid Subtypes in Cell-Mediated Immunity.
Neuroimmunodulation 1994, 1, 141-147.
(14) (a) Hammond, D. L. Pharmacological Mechanisms of Pain
Modulation. An Update on δ Receptors. In Current and Emerg-
ing Issues in Cancer Pain: Research and Practice; Chapman,
C. R., Foley, K. M., Eds.; Raven Press: New York, 1993; pp 175-
183. (b) Ziegler, D. K. Opiate and Opioid Use in Patients with
Refractory Headache. Cephalagia 1995, 14, 5-10. (c) Portenoy,
R. K. Opioid Therapy for Chronic Nonmalignant Pain: A Review
of the Critical Issues. J . Pain Sympt. Manag. 1996, 11, 203-
217.
(15) Abdelhamid, E. E.; Sultana, M.; Portoghese, P. S.; Takemori,
A. E. Selective Blockage of Delta Opioid Receptors Prevents the
Development of Morphine Tolerance and Dependence in Mice.
J . Pharmacol. Exp. Ther. 1991, 258, 299-303.
(16) (a) Froelich, J . C.; Li, T.-K. Opioid Peptides. In Recent Develop-
ments in Alcoholism, Volume II: Ten Years of Progress; Galanter,
M., Ed.; Plenum Press: New York, 1995; pp 187-205. (b)
Terenius, L. Alcohol Addiction (Alcoholism) and the Opioid
System. Alcohol 1996, 13, 31-34.
(17) Gillberg, C. Endogenous Opioids and Opiate Antagonists in
Autism: A Brief Review of Empirical Findings and Implications
for Clinicians. Dev. Med. Child Neurol. 1995, 37, 239-245.
(18) (a) Erspamer, V. The Opioid Peptides of the Amphibian Skin.
Int. J . Dev. Neurosci. 1992, 10, 3-30. (b) Lazarus, L. H.; Attila,
M. The Toad, Ugly and Venomous, Wears Yet a Precious J ewel
in His Skin. Prog. Neurobiol. 1993, 41, 473-507.
(19) Hruby, V. J .; Gehrig, C. A. Recent Developments in the Design
of Receptor Specific Opioid Peptides. Med. Res. Rev. 1989, 9,
343-401.
(20) (a) Lazarus, L. H.; Salvadori, S.; Tomatis, R.; Wilson, W. E.
Opioid Receptor Selectivity Reversal in Deltorphin Tetrapeptide
Analogues. Biochem. Biophys. Res. Commun. 1991, 178, 110-
115. (b) Charpentier, S.; Sagan, S.; Delfour, A.; Nicolas, P.
Dermenkephalin and Deltorphin I Reveal Similarities within
Ligand-Binding Domains of µ- and δ-Opioid Receptors and an
Additional Address Subsite on the δ-Receptor. Biochem. Biophys.
Res. Commun. 1991, 179, 1161-1168.
(21) Lazarus, L. H.; de Castiglione, R.; Guglietta, A.; Wilson, W. E.
Highly Selective δ-Opioid Receptor Peptide from Preprodermor-
phin Gene Sequence. J . Biol. Chem. 1989, 264, 3047-3050.
(22) Mor, A.; Delfour, A.; Sagan, S.; Amiche, M.; Pradelles, P.; Rossier,
J .; Nicolas, P. Isolation of Dermenkephalin from Amphibian
Skin, a High-Affinity δ-Selective Opioid Heptapeptide Contain-
ing a D-Amino Acid Residue. FEBS Lett. 1989, 255, 269-274.
(23) Kreil, G.; Barra, D.; Simmaco, M.; Erspamer, V.; Falconieri
Erspamer, G.; Negri, L.; Severini, C.; Corsi, R.; Melchiorri, P.
Deltorphin, A Novel Amphibian Skin Peptide with High Selec-
tivity and Affinity for δ Opioid Receptors. Eur. J . Pharmacol.
1989, 162, 123-128.
(24) Erspamer, V.; Melchiorri, P.; Falconieri Erspamer, G.; Negri,
L.; Corsi, R.; Severini, C.; Barra, D.; Simmaco, M.; Kreil, G. Del-
torphins: A Family of Naturally Occurring Peptides with High
Affinity and Selectivity for 2 Opioid Binding Sites. Proc. Natl.
Acad. Sci. U.S.A. 1989, 86, 5188-5192.
(25) Richter, K.; Egger, R.; Negri, L.; Corsi, R.; Severini, C.; Kreil,
G. cDNAs Encoding [D-Ala2]Deltorphin Precursors from Skin
of Phyllomedusa Bicolor Also Contain Genetic Information for
Three Dermorphin-Related Opioid Peptides. Proc. Natl. Acad.
Sci. U.S.A. 1990, 87, 4836-4839.
(26) Lazarus, L. H.; Salvadori, S.; Balboni, G.; Tomatis, R.; Wilson,
W. E. Stereospecificity of Amino Acid Side Chains in Deltorphin
Defines Binding to Opioid Receptors. J . Med. Chem. 1992, 35,
1222-1227.
(27) Bryant, S. D.; Attila, M.; Salvadori, S.; Guerrini, R.; Lazarus,
L. H. Molecular Dynamics Conformations of Deltorphin Ana-
logues Advocated δ Opioid Binding Site Models. Peptide Res.
1994, 7, 175-184.
(28) Salvadori, S.; Bianchi, C.; Lazarus, L. H.; Scaranari, V.; Attila,
M.; Tomatis, R. Para-Substituted Phe3 Deltorphin Analogues:
Enhanced Selectivity of Halogenated Derivatives for δ Opioid
Receptor Sites. J . Med. Chem. 1992, 35, 4651-4657.
(29) Schiller, P. W.; Nguyen, T. M.-D.; Weltrowska, G.; Lemieux, C.;
Chung, N. N. Development of [D-Ala2]Deltorphin I Analogs with
Extraordinary Delta Receptor Selectivity. In New Leads in
Opioid Research; van Ree, J . M., Mulder, A. H., Wiegant, V. M.,
van Wimersma Greidanus, T. B., Eds.; Excerpta Medica: Am-
sterdam, 1990; pp 288-290.
(30) Salvadori, S.; Bryant, S. D.; Bianchi, C.; Balboni, G.; Attila, M.;
Lazarus, L. H. Phe3-Substituted Analogues of Deltorphin C.
Spatial Conformation and Topography of the Aromatic Ring in
Peptide Recognition by δ Opioid Receptors. J . Med. Chem. 1993,
36, 3748-3756.
(31) (a) Heyl, D. L.; Schmitter, S. J .; Bouzit, H.; J ohnson, T. W.; Hepp,
A. M.; Kurtz, K. R.; Mousigian, C. Substitution of Aromatic and
Nonaromatic Amino Acids for the Phe3 Residue in the δ-Selective
Opioid Peptide Deltorphin I: Effects on Binding Affinity and
Selectivity. Int. J . Pept. Protein Res. 1994, 44, 420-426. (b) Heyl,
D. L.; Dandabathula, M.; Kurtz, K. R.; Mousigian, C. Opioid
Receptor Binding Requirements for the δ-Selective Peptide
Deltorphin I: Phe3 Replacement with Ring-Substituted and
Heterocyclic Amino Acids. J . Med. Chem. 1995, 38, 1242-1246.
(32) Breveglieri, A.; Guerrini, R.; Salvadori, S.; Bianchi, C.; Bryant,
S. D.; Attila, M.; Lazarus, L. H. Design and Synthesis of
1-Aminocycloalkane-1-carboxylic Acid Substituted Deltorphin
Analogues: Unique δ and µ Opioid Activity in Modified Peptides.
J . Med. Chem. 1996, 39, 773-780.
(33) Lazarus, L. H.; Bryant, S. D.; Salvadori, S.; Attila, M.; J ones,
L. S. Opioid Infidelity: Novel Opioid Peptides with Dual High
Affinity for δ- and µ-Receptors. Trends Neurosci. 1996, 19, 31-
35.
(34) Balboni, G.; Marastoni, M.; Picone, D.; Salvadori, S.; Tancredi,
T.; Temussi, P. A.; Tomatis, R. New Features of the δ Opioid
Receptor: Conformational Properties of Deltorphin I Analogues.
Biochem. Biophys. Res. Commun. 1990, 169, 617-622.
(35) Amodeo, P.; Motta, A.; Tancredi, T.; Salvadori, S.; Tomatis, R.;
Picone, D.; Saviano, G.; Temussi, P. A. Solution Structure of
Deltorphin I at 265 K: A Quantitative NMR Study. Peptide Res.
1992, 5, 48-55.
(36) Bryant, S. D.; Salvadori, S.; Attila, M.; Lazarus, L. H. Topo-
graphical Conformations of the Deltorphins Predicate δ Opioid
Receptor Affinity. J . Am. Chem. Soc. 1993, 115, 8503-8504.
(37) (a) Temussi, P. A.; Picone, D.; Tancredi, T.; Tomatis, R.;
Salvadori, S.; Marastoni, M.; Balboni, G. Conformational Prop-
erties of Deltorphin: New Features of the δ-Opioid Receptors.
FEBS Lett. 1989, 247, 283-288. (b) Tancredi, T.; Temussi, P.
A.; Picone, D.; Amodeo, P.; Tomatis, R.; Salvadori, S.; Marastoni,
M.; Santagada, V.; Balboni, G. New insights on µ/δ Selectivity
of Opioid Peptides: Conformational Analysis of Deltorphin
Analogues. Biopolymers 1991, 31, 751-760.
(38) Duchnesne, D.; Naim, M.; Nicolas, P.; Baron, D. Folding Trends
in a Flexible Peptide: Two Dimensional NMR* Study of Del-
torphin-I, a δ Selective Opioid Heptapeptide. Biochem. Biophys.
Res. Commun. 1993, 195, 630-636.
(39) Balaji, V. N.; Ramnarayan, K.; Chan, M. F.; Rao, S. N. Confor-
mational Studies on Model Peptides with 1-Aminocyclopropane-
1-carboxylic Acid Residues. Peptide Res. 1994, 7, 60-71.
(40) Kabsch, W.; Sander, C. Dictionary of Protein Secondary Struc-
ture: Pattern Recognition of Hydrogen-Bonded and Geometrical
Features. Biopolymers 1983, 22, 2577-2637.
(41) Schiller, P. W.; Nguyen, T. M.-D.; Chung, N. N.; Lemieux, C.
Dermorphin Analogues Carrying an Increased Positive Net
Charge in their “Message” Domain Display Extremely High µ
Opioid Receptor Selectivity. J . Med. Chem. 1989, 32, 698-703.
(42) Schiller, P. W.; Weltrowska, G.; Nguyen, T. M.-D.; Wilkes, B.
C.; Chung, N. N.; Lemieux, C. Conformationally Restricted
Deltorphin Analogues. J . Med. Chem. 1992, 35, 3956-3561.
(43) Ro´nai, A. Z.; Magyar, A.; Orosz, G.; Borsodi, A.; Benyhe, S.; To´th,
G.; Mako´, EÄ .; K tay, E.; Babka, E.; Medzihradszky, K. Opioid
Antagonist Properties of the Highly δ-Receptor-Selective BOC-
Tyr-Pro-Gly-Phe-Leu-Thr(OtBu) Peptide and of its Phe1 and Met1
Analogues. Arch. Int. Pharmocodyn. 1995, 330, 361-369.
(44) (a) Amiche, M.; Sagan, S.; Mor, A.; Delfour, A.; Nicolas, P.
Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): A Po-
tent and Fully Specific Agonist for the δ Opioid Receptor. Mol.
Pharmacol. 1989, 35, 774-779. (b) Sagan, S.; Amiche, M.;
Delfour, A.; Camus, A.; Mor, A.; Nicolas, P. Differential Contri-
bution of C-Terminal Regions of Dermorphin and Dermenkepha-
lin to Opioid-Sites Selection and Binding Potency. Biochem.
Biophys. Res. Commun. 1989, 163, 726-732. (c) Melchiorri, P.;
Negri, L.; Falconieri-Erspamer, G.; Severini, C.; Corsi, R.; Soaje,
M.; Erspamer, V.; Barra, D. Structure-Activity Relationships of
the δ-Opioid Selective Agonists, Deltorphins. Eur. J . Pharmacol.
1991, 195, 201-207.
(45) Schmidt, R.; Chung, N. N.; Lemieux, C.; Schiller, P. W. Tic2-
Substitution in Dermorphin, Deltorphin I and Dynorphin A
Analogues: Effect on Opioid Receptor Binding and Opioid
Activity In Vitro. Reg. Pept. 1994, 54, 259-260.
(46) Salvadori, S.; Guerrini, R.; Forlani, V.; Bryant, S. D.; Attila, M.;
Lazarus, L. H. Prerequisite for His4 in Deltorphin A for High δ
Opioid Receptor Selectivity. Amino Acids 1994, 7, 291-304.
(47) (a) Evans, C. J .; Keith, D. E., J r.; Morrison, H.; Magendzo, K.;
Edwards, R. H. Cloning of a Delta Opioid Receptor by Functional
Expression. Science 1992, 258, 1952-1955. (b) Kieffer, B. L.;
Befort, K.; Gaveriaux-Ruff, C.; Hirth, C. G. The δ-Opioid
Receptor: Isolation of a cDNA by Expression Cloning and
Pharmacological Characterization. Proc. Natl. Acad. Sci. U.S.A.
1992, 89, 12048-12052. (c) Chen, Y.; Mestek, A.; Liu, J .; Yu, L.